Human trials show enriched boswellia extract reduces knee pain and supports physical function. That is why 100 mg boswellia extract providing 30 mg AKBA leads Mobility’s daily formula.
49% improvement after 90 days.
In a controlled trial, adults with knee osteoarthritis took 100 mg of boswellia extract providing 30 mg AKBA every day. After 90 days, the group’s standard knee-pain score improved by 48.83% compared with placebo.
See the trial and its results →
The result stands on more than one study.
Five boswellia studies reviewed
A Cochrane review examined five boswellia studies. Its strongest comparison found 100 mg of enriched boswellia improved pain and physical function after 90 days.
32% lower knee pain in a second trial
A separate controlled trial tested 100 mg of enriched boswellia daily and reported a 31.6% improvement in a standard knee-pain score versus placebo after 90 days.
Why these ingredients are in Mobility.
100 mg boswellia extract
Boswellia leads the formula. It provides 30 mg AKBA, the same daily AKBA amount used in the lead 100 mg human trial.
200 mg moringa extract
Moringa adds antioxidant plant compounds alongside boswellia.